This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Emerson Radio, ShoreTel: Volume Movers

BOSTON ( TheStreet) -- Emerson Radio (MSN - Get Report) was one of several stocks trading near $5 poised to move on above-average volume Thursday after the company said it swung to a fiscal fourth-quarter profit.

Emerson Radio said it had fiscal fourth-quarter net income from continuing operations of $3.6 million, or 13 cents a share, swinging from a year-ago loss of $2.2 million, or 8 cents a share. Fiscal fourth-quarter revenue was up 19.5% to $51.5 million, mostly due to increased sales of microwave ovens, the company said.

Shares of Emerson Radio jumped by 30 cents, or 17%, to $2.07 in the premarket session. The average daily share volume for Emerson Radio is 39,000.

Elsewhere, Arena Pharmaceuticals (ARNA - Get Report) traded higher ahead of the Food and Drug Administration advisory panel meeting Thursday to review Vivus' (VVUS) weight-loss drug Qnexa. TheStreet's Adam Feuerstein will be live blogging the FDA advisory panel's meeting beginning at 7:45 a.m. ET.

Shares of Arena Pharmaceuticals added 40 cents, or 9.4%, to $4.68 in the premarket session. The average daily share volume for Arena Pharmaceuticals is 4.65 million.

ShoreTel (SHOR - Get Report) rose by 11 cents, or 2%, to $5.50 in Wednesday's after-market session after the company upped its revenue forecast for the company's fiscal fourth quarter, saying it expects to report revenue of $41 million to $42 million. The Internet phone and messaging systems provider previously said it expected fiscal fourth-quarter revenue of $35 million to $38 million. In addition, ShoreTel CEO John Combs said he will leave the company. The average daily share volume for ShoreTel is 116,000.

Lakes Entertainment (LACO) jumped by 17 cents, or 6.9%, to $2.63 in Wednesday's after-house session after the company said it has received $25 million from Penn National Gaming as part of a termination agreement where Lakes Entertainment will relinquish all right, title and interest it had in the casino projects in Columbus, Ohio and Toledo, Ohio.

"Although we believe the Toledo and Columbus casinos will be very successful, receiving $25 million now is a good return on our investment with Penn," Lakes Chairman and CEO Lyle Berman said in a statement.. The average daily share volume for Lakes Entertainment is 166,000.

On the downside, Oxygen Biotherapeutics (OXBT) fell by 11 cents, or 4%, to $2.65 in Wednesday's after-market session after the company's Chairman and CEO Chris Stern said in a letter to shareholders that the company has transitioned from a "smaller reporting company" to an "accelerated filer" as defined by the Securities and Exchange Commission.

Due to the accelerated filer deadlines and the need to provide an independent auditor's attestation report, Stern said Oxygen Biotherapeutics needs additional time to finalize the required disclosures and documentation for our Form 10-K for the fiscal year, although he expects the company will file the 10-K within the permitted 15-day extension period. The average daily share volume for Oxygen Bioteherapeutics is 25,000.

Meanwhile, Peregrine Pharmaceuticals (PPHM - Get Report) were poised to trade on increased volume after the company said it had a fiscal fourth-quarter loss of $7.7 million, or 16 cents a share, widening from a year-ago loss of $3.6 million, or 9 cents a share. Revenue dropped to $4.4 million in the recent quarter, down from $7.9 million in the year-ago quarter.

Analysts forecasted a loss of 9 cents a share on revenue of $6.9 million, according to Thomson Reuters.. The average daily share volume for Peregrin Pharmaceuticals is 816,000.

-- Written by Robert Holmes in Boston.

Check out all of Thursday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of on Facebook.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
OXBT $3.71 1.71%
ARNA $1.58 0.00%
LACO $12.68 1.44%
MSN $0.78 0.00%
PPHM $0.33 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs